First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx

More documents

Recommendations

Info

Preliminary observations: VWF:Ag (n = 5/110) Normal range 26
Preliminary observations: FV<strong>II</strong>I acitivity (n = 5/110) 27
Page 1 and 2: First results of the Phase II TITAN
Page 3 and 4: Clinical symptoms at the first thre
Page 5 and 6: ADAMTS13 • VWF cleaving protease
Page 7 and 8: Treatment of acute TTP • Survival
Page 9 and 10: Immunosuppressive agents • Cortic
Page 11 and 12: Perspectives • Recombinant ADAMTS
Page 13 and 14: ALX-0081: mode of action in TTP •
Page 15 and 16: ALX-0081 potently neutralises ULVWF
Page 17 and 18: The TITAN trial: study design Inclu
Page 19 and 20: Nanobodies ® - Inspired by nature
Page 21 and 22: Demographic and baseline characteri
Page 23 and 24: PE details • PE treatment - varia
Page 25: Preliminary observations: RiCo (n =
Page 29 and 30: Preliminary observations: anti-ADAM
Page 31 and 32: Serious adverse events • 2 SAEs r
Page 33: Acknowledgements • Hemophilia and

First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?